These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8782175)

  • 1. Optimal detection of blood-brain barrier defects with Gd-DTPA MRI-the influences of delayed imaging and optimised repetition time.
    Tofts PS
    Magn Reson Imaging; 1996; 14(4):373-80. PubMed ID: 8782175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model.
    Tofts PS; Berkowitz B; Schnall MD
    Magn Reson Med; 1995 Apr; 33(4):564-8. PubMed ID: 7776889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts.
    Tofts PS; Kermode AG
    Magn Reson Med; 1991 Feb; 17(2):357-67. PubMed ID: 2062210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of blood-brain barrier permeability using dynamic Gd-DTPA scanning--a comparison of methods.
    Larsson HB; Tofts PS
    Magn Reson Med; 1992 Mar; 24(1):174-6. PubMed ID: 1556924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approximation of arterial input curve data in MRI estimation of cerebral blood-tumor-barrier leakage: comparison between Gd-DTPA and 99mTc-DTPA input curves.
    Andersen C; Taagehøj JF; Mühler A; Rehling M
    Magn Reson Imaging; 1996; 14(3):235-41. PubMed ID: 8725189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capillary leakage of a macromolecular MRI agent, carboxymethyldextran-Gd-DTPA, in the liver: pharmacokinetics and imaging implications.
    Siauve N; Clément O; Cuénod CA; Benderbous S; Frija G
    Magn Reson Imaging; 1996; 14(4):381-90. PubMed ID: 8782176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of capillary permeability from the Gd enhancement curve: a comparison of bolus and constant infusion injection methods.
    Tofts PS; Berkowitz BA
    Magn Reson Imaging; 1994; 12(1):81-91. PubMed ID: 8295511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs.
    Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H; Weinmann HJ
    Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS.
    Filippi M; Yousry T; Campi A; Kandziora C; Colombo B; Voltz R; Martinelli V; Spuler S; Bressi S; Scotti G; Comi G
    Neurology; 1996 Feb; 46(2):379-84. PubMed ID: 8614498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance imaging observations of blood-brain-barrier permeability in an animal model of brain injury.
    Ford JC; Wood AK; Van Winkle TJ; Kundel HL
    Acad Radiol; 1997 Feb; 4(2):115-26. PubMed ID: 9061084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-retinal barrier breakdown investigated by real-time magnetic resonance imaging after gadolinium-diethylenetriaminepentaacetic acid injection.
    Berkowitz BA; Sato Y; Wilson CA; de Juan E
    Invest Ophthalmol Vis Sci; 1991 Oct; 32(11):2854-60. PubMed ID: 1917389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium DTPA-enhanced magnetic resonance imaging of cerebral contusions.
    Kushi H; Katayama Y; Shibuya T; Tsubokawa T; Kuroha T
    Acta Neurochir Suppl (Wien); 1994; 60():472-4. PubMed ID: 7976623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of blood-brain barrier permeability in a tumor model using magnetic resonance imaging with gadolinium-DTPA.
    Kenney J; Schmiedl U; Maravilla K; Starr F; Graham M; Spence A; Nelson J
    Magn Reson Med; 1992 Sep; 27(1):68-75. PubMed ID: 1435211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.
    Filippi M; Capra R; Campi A; Colombo B; Prandini F; Marcianò N; Gasparotti R; Comi G
    J Neurol Neurosurg Psychiatry; 1996 May; 60(5):526-30. PubMed ID: 8778257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependency in brain lesion enhancement with gadodiamide injection.
    Akeson P; Nordström CH; Holtås S
    Acta Radiol; 1997 Jan; 38(1):19-24. PubMed ID: 9059396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosis.
    Filippi M; Campi A; Martinelli V; Colombo B; Yousry T; Canal N; Scotti G; Comi G
    J Neurol Neurosurg Psychiatry; 1995 Nov; 59(5):540-4. PubMed ID: 8530944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging.
    Tofts PS
    J Magn Reson Imaging; 1997; 7(1):91-101. PubMed ID: 9039598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI.
    Berkowitz BA; Tofts PS; Sen HA; Ando N; de Juan E
    Invest Ophthalmol Vis Sci; 1992 Dec; 33(13):3500-6. PubMed ID: 1464496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional comparison of tumor vascularity and permeability parameters measured by albumin-Gd-DTPA and Gd-DTPA.
    Su MY; Najafi AA; Nalcioglu O
    Magn Reson Med; 1995 Sep; 34(3):402-11. PubMed ID: 7500880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic imaging of contrast enhancement in brain tumors.
    Bullock PR; Mansfield P; Gowland P; Worthington BS; Firth JL
    Magn Reson Med; 1991 Jun; 19(2):293-8. PubMed ID: 1881318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.